Fulgent Genetics, Inc. ( FLGT) - Key Metrics
FLGT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.05 | -$1.05 | -$0.85 | -$0.99 |
| 2026Q1 | $2.30 | -$0.80 | $0.23 | $0.06 |
| 2025Q4 | $2.71 | -$0.76 | -$2.54 | -$2.70 |
| 2025Q3 | $2.73 | -$0.21 | $0.36 | $0.16 |
| 2025Q2 | $2.65 | -$0.61 | -$0.98 | -$1.20 |
FLGT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.89 |
| 2026Q1 | 0% | -4.97 |
| 2025Q4 | 0% | -8.64 |
| 2025Q3 | 0% | -26.90 |
| 2025Q2 | 0% | -8.15 |
FLGT
Price: $19.44
52 week price:
Earnings Per Share: -2.99 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 235500
Ebitda: -1.0 millionMarket Capitalization: 560.3 million